TY - JOUR
T1 - Hepatobiliary manifestations in inflammatory bowel disease
T2 - A practical approach
AU - F, Paulina Núñez
AU - Castro, Fabiola
AU - Mezzano, Gabriel
AU - Quera, Rodrigo
AU - Diaz, Diego
AU - Castro, Lorena
N1 - Publisher Copyright:
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
PY - 2022/2/27
Y1 - 2022/2/27
N2 - Inflammatory bowel diseases (IBD) are associated with various hepatobiliary disorders. They can occur at any moment in the course of the disease or associated with the treatment. The prevalence of liver dysfunction can reach up to 50% in different studies. Nonalcoholic fatty liver disease is considered the most common hepatobiliary complication in IBD, while primary sclerosing cholangitis is the most specific. Management of hepatic manifestations in IBD involves a multidisciplinary approach that includes a high index of suspicion and joint management with hepatologists. The medical confrontation with abnormal liver tests must include an exhaustive study to determine if these patterns can be related to IBD, associated diseases or to the therapies used.
AB - Inflammatory bowel diseases (IBD) are associated with various hepatobiliary disorders. They can occur at any moment in the course of the disease or associated with the treatment. The prevalence of liver dysfunction can reach up to 50% in different studies. Nonalcoholic fatty liver disease is considered the most common hepatobiliary complication in IBD, while primary sclerosing cholangitis is the most specific. Management of hepatic manifestations in IBD involves a multidisciplinary approach that includes a high index of suspicion and joint management with hepatologists. The medical confrontation with abnormal liver tests must include an exhaustive study to determine if these patterns can be related to IBD, associated diseases or to the therapies used.
KW - Extraintestinal manifestations
KW - Hepatic steatosis
KW - Inflammatory bowel disease
KW - Liver toxicity
KW - Sclerosing primary cholangitis
KW - Extraintestinal manifestations
KW - Hepatic steatosis
KW - Inflammatory bowel disease
KW - Liver toxicity
KW - Sclerosing primary cholangitis
UR - http://www.scopus.com/inward/record.url?scp=85125286536&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/e7618b3f-7ee8-3e2b-a2a8-e40df3d2386a/
U2 - 10.4254/wjh.v14.i2.319
DO - 10.4254/wjh.v14.i2.319
M3 - Review article
C2 - 35317174
AN - SCOPUS:85125286536
SN - 1948-5182
VL - 14
SP - 319
EP - 337
JO - World Journal of Hepatology
JF - World Journal of Hepatology
IS - 2
ER -